Susan Percy Ivy

20PUBLICATIONS
187CO-AUTHORS
Radiation therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 07, 2026
Multicenter, Randomized, Phase II Trial of Olaparib Plus Radium-223 Versus Radium-223 in Men With Castration-Resistant Prostate Cancer With Bone Metastases (COMRADE).

|Feb 07, 2025
Olaparib in treatment-refractory isocitrate dehydrogenase 1 (IDH1)- and IDH2-mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2 National Cancer Institute 10129 trial.

Michael Cecchini, Mary Jo Pilat, Nataliya Uboha

|Jan 14, 2025
Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials.

Jia Liu, Max Farrow, Lesley Seymour

|Oct 14, 2024
Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy Participants.

Yingmiao Liu, Jiatong Li, Jing Lyu

|Apr 11, 2024
Phase II Study of Erdafitinib in Patients With Tumors With <i>FGFR</i> Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1.

Jun Gong, Alain C Mita, Zihan Wei

|Apr 11, 2024
Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2.

Jun Gong, Alain C Mita, Zihan Wei

Pageof 4

Frequent Collaborators

4 joint publications

Geoffrey I Shapiro

3 joint publications

Lisa M McShane

3 joint publications

Lesley Seymour

3 joint publications

Bose S Kochupurakkal